source
- BMS reports patient death in MS CAR-T trial, cites septic pneumonia and pauses enrollmentBMS disclosed details about a patient death that occurred in its investigational CAR-T therapy for multiple sclerosis. The autologous CD19-directed CAR-T, zolacabtagene autoleucel (zola-cel), had…
- US proposes new biotech investment limits on China, but licensing deals remain allowedThe U.S. Treasury announced a proposal to curb outbound investments in Chinese biotechnology, citing national‑security concerns. The plan would limit U.S. persons from funding certain bio‑derived c…